##plugins.themes.bootstrap3.article.main##

Hugo Valenzuela C. Mirtha Reyes H. Claudia Pino V. Mauricio Tapia G.

Abstract

Idiopathic pulmonary fibrosis (IPF) has been classified as mild or early - moderate - severe or advanced disease, with no cut-off points in clinical, functional or imaging parameters. There is no consensus yet on which is the main parameter to be measured although the functional variables such as forced vital capacity (FVC), carbon monoxide diffusion capacity (DLCO) and 6-minute walk test, have been routinely used in clinical practice and in the main clinical studies of treatment, are often
not representative of the clinical evolution. Therefore, composite indices or scores such as the GAP (Gender-Age-Physiology) scale have been developed that could be useful in the follow-up of patients.

##plugins.themes.bootstrap3.article.details##

Keywords.

Idiopathic pulmonary fibrosis, Follow-Up of Studies, Vital Capacity, Walk test

Section
Artícules

How to Cite

Valenzuela C., H., Reyes H., M., Pino V., C., & Tapia G., M. (2020). How to monitor patients with idiopathic pulmonary fibrosis?. Revista Chilena De Enfermedades Respiratorias, 35(4), 304–307. Retrieved from https://revchilenfermrespir.cl/index.php/RChER/article/view/863

Most read articles by the same author(s)